Search results
13 sie 2020 · Cancer-associated anemia is caused by 1 or more of 3 primary mechanisms: (1) ineffective erythropoiesis, 4,27 (2) hemolysis, or (3) blood loss. 28 Our approach subclassifies potential causes of cancer-associated anemia by first listing 3 broad categories: production, destruction, and loss (bleeding).
red blood cell transfusions are rapid increase of hemoglobin concentration and effectiveness independent of the cause of anemia. However, several adverse reactions may occur after blood component transfusion.
Anemia is usually multifactorial in patients with cancer; possible contributing factors include bleeding, nutritional deficiencies, hemolysis, reduced erythropoietin levels, inflammation with increased hepcidin activity, and the toxic effects of chemotherapy in marrow precursors.
2 wrz 2020 · Serum samples with 0.1%, 0.3%, 1%, 3%, and 10% hemolysis were prepared from sonicated endogenous red blood cells and received 35 wet and 22 dry clinical biochemical tests, respectively.
9 lip 2024 · In DIIHA, the presence of bite cells, blister cells, or irregularly shaped RBCs (poikilocytosis) suggests oxidative hemolysis, while spherocytes or microspherocytes indicate immune hemolysis. Schistocytes, on the other hand, suggest a thrombotic microangiopathy such as disseminated intravascular coagulation.
15 sie 2022 · The process of red blood cell destruction — including premature red blood cell destruction — is called hemolysis. Having too few red blood cells because of hemolysis causes a condition called hemolytic anemia.
3 wrz 2002 · The hallmark of hemolysis is shortened red blood cell survival in the peripheral blood. Hemolysis results in anemia only when bone marrow cannot keep up with the rate of red cell destruction. Even though anemia is very commonly observed in most cancer patients, hemolytic anemias are rather rare.
